#South Korea #Seongnam #Rejuran #PharmaResearch #VIVACY

PharmaResearch Announces Strategic Partnership with VIVACY

PharmaResearch, a leading player in regenerative medicine based in South Korea, has recently finalized a significant agreement with Laboratoires VIVACY, a prominent French company specializing in medical aesthetics. This partnership aims to facilitate the distribution of Rejuran, a cutting-edge medical product, across 22 countries in Europe.

Strategic Importance of the Partnership

The collaboration between PharmaResearch and VIVACY is poised to significantly enhance the market presence of Rejuran, a product renowned for its unique PN (Polynucleotide) formulation, currently the only one of its kind approved under EU medical regulations. Recognized as a key player in the European medical aesthetics industry, VIVACY has established a robust commercial and marketing network, including offices and branches in major cities throughout Europe.

With this partnership, PharmaResearch plans to leverage VIVACY’s extensive distribution channels and market expertise to expedite the launch of Rejuran in prominent European markets, including the UK, Germany, France, Italy, and Spain.

Financial Overview

The agreement, valued at approximately 54.5 million euros over a five-year term, encompasses a strategic expansion into crucial Western European markets. PharmaResearch’s CEO, Jihoon Sohn, expressed confidence in the partnership's ability to enhance the global visibility of Rejuran and cement its position as a leader in the international medical aesthetics market.

VIVACY's Role and Insights

Bertrand, CEO of VIVACY, highlighted the synergy created by this partnership, citing Rejuran’s positioning as a premium brand coupled with VIVACY’s strong scientific reputation and commercial acumen as factors that could lead to a successful market launch. The aim is to provide healthcare professionals with exemplary Polynucleotide technology and offer patients advanced skin regeneration solutions.

PharmaResearch Overview

Founded with the mission to improve quality of life through innovative regenerative medicine, PharmaResearch boasts a diverse portfolio, including pharmaceuticals, medical products, cosmetics, and dietary supplements. Their research is driven by a focus on core ingredients protected by a series of patents, notably DOT™ PDRN and DOT™ PN. The company is headquartered in Gangneung, South Korea, with an operational branch located in Costa Mesa, California.

For more information, visit PharmaResearch's official website.

About Laboratoires VIVACY

Founded in 2007, Laboratoires VIVACY is a French manufacturer known for its high-quality hyaluronic acid-based medical products. With its proprietary IPN-like technology, VIVACY is particularly recognized for its STYLAGE® dermal fillers and DESIRIAL®, the world’s first injectable product for both functional and aesthetic gynecology. VIVACY also collaborates with Burgeon Biotechnology for their NOVUMA® biostimulator. Manufacturing takes place in their state-of-the-art facility located in Archamps Technopole, France, with a presence in over 85 countries worldwide.

For additional details, please check VIVACY's website.